TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC
Clinical trial NCT04992143 · UNKNOWN
Trial details
- NCT number
- NCT04992143
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-20
- Primary completion
- 2023-08-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.